全文获取类型
收费全文 | 1375篇 |
免费 | 222篇 |
国内免费 | 16篇 |
出版年
2024年 | 7篇 |
2023年 | 30篇 |
2022年 | 57篇 |
2021年 | 66篇 |
2020年 | 49篇 |
2019年 | 83篇 |
2018年 | 49篇 |
2017年 | 59篇 |
2016年 | 55篇 |
2015年 | 63篇 |
2014年 | 140篇 |
2013年 | 133篇 |
2012年 | 99篇 |
2011年 | 88篇 |
2010年 | 42篇 |
2009年 | 47篇 |
2008年 | 57篇 |
2007年 | 49篇 |
2006年 | 61篇 |
2005年 | 43篇 |
2004年 | 37篇 |
2003年 | 29篇 |
2002年 | 27篇 |
2001年 | 27篇 |
2000年 | 27篇 |
1999年 | 18篇 |
1998年 | 25篇 |
1997年 | 17篇 |
1996年 | 14篇 |
1995年 | 17篇 |
1994年 | 13篇 |
1993年 | 17篇 |
1992年 | 10篇 |
1991年 | 10篇 |
1990年 | 8篇 |
1989年 | 8篇 |
1988年 | 2篇 |
1987年 | 5篇 |
1986年 | 4篇 |
1985年 | 4篇 |
1984年 | 2篇 |
1983年 | 4篇 |
1982年 | 1篇 |
1981年 | 1篇 |
1980年 | 3篇 |
1978年 | 3篇 |
1977年 | 1篇 |
1975年 | 1篇 |
1970年 | 1篇 |
排序方式: 共有1613条查询结果,搜索用时 343 毫秒
1.
《Free radical research》2013,47(2):82-88
AbstractEndothelial dysfunction characterized by decreased nitric oxide (NO) bioavailability is the first stage of coronary artery disease. It is known that one of the factors associated with an increased risk of coronary artery disease is a high plasma level of uric acid. However, causative associations between hyperuricaemia and cardiovascular risk have not been definitely proved. In this work, we tested the effect of uric acid on endothelial NO bioavailability. Electrochemical measurement of NO production in acetylcholine-stimulated human umbilical endothelial cells (HUVECs) revealed that uric acid markedly decreases NO release. This finding was confirmed by organ bath experiments on mouse aortic segments. Uric acid dose-dependently reduced endothelium-dependent vasorelaxation. To reveal the mechanism of decreasing NO bioavailability we tested the effect of uric acid on reactive oxygen species production by HUVECs, on arginase activity, and on acetylcholine-induced endothelial NO synthase phosphorylation. It was found that uric acid increases arginase activity and reduces endothelial NO synthase phosphorylation. Interestingly, uric acid significantly increased intracellular superoxide formation. In conclusion, uric acid decreases NO bioavailability by means of multiple mechanisms. This finding supports the idea of a causal association between hyperuricaemia and cardiovascular risk. 相似文献
2.
在31只氯醛糖和氨基甲酸乙酯麻醉的猫,观察了选择性激活颈动脉压力和化学感受器对巨细胞旁外侧核(PGL)单位放电的影响。136个PGL自发放电单位中,有84个在激活颈动脉压力感受器(BA)(新福林,1—2μg/kg,iv)和/或激活颈动脉化学感受器(CA)(nicotine 5—20μg,溶于0.25—0.5ml生理盐水中,注入甲状腺动脉)时,放电频率有变化。在这些有反应的单位中,16个仅对CA起反应(11个兴奋、5个抑制);54个以各种组合方式对CA和BA都起反应,其中以CA引起兴奋反应而BA引起抑制反应的占比例最大;14个仅对BA起反应(7个兴奋,7个抑制)。在定位分布上,那些只对CA起反应的单位多位于PGL的腹侧部份;仅对BA起反应的单位则位于对CA起反应单位的较背侧;对BA和CA均起反应的单位介于上述两者之间或在较深区域。这些结果表明,颈动脉区压力和化学感受器活动传入到PGL,并会聚在其中一些神经元上。 在PGL内全部有反应的单位中,68个对激活颈动脉压力感受器起反应,其中兴奋的29个,抑制的39个(P>0.05);70个对激活颈动脉化学感受器起反应,其中48个兴奋,22个抑制(P<0.005)。这些结果提示,BA对PGL神经元引起兴奋和抑制两种效应,而CA则诱发兴奋为主的反应。 相似文献
3.
Summary The localization of vasopressin, serotonin and angiotensin II in the endothelial cells of renal and mesenteric arteries was investigated using the pre-embedding peroxidase-antiperoxidase technique for electron microscopy. Vasopressin-and serotonin-positive endothelial cells were present in both renal and mesenteric arteries while angiotensin II-positive cells were observed in the mesenteric artery exclusively. Both arteries showed less than 10% immunoreactive cells. The lack of angiotensin II in the endothelial cells of the renal artery suggests that there may be subtle physiological differences between the renal and mesenteric arteries with respect to the local control of blood flow. 相似文献
4.
Mária Zsófia Koltai Peter Rösen Pál Hadházy Zoltán Aranyi György Ballagi-Pordány Gábor Pogátsa 《Molecular and cellular biochemistry》1992,109(2):189-196
The aim of this study was to clarify whether or not arachidonic acid metabolic disorders are caused by a substrate inavailability and whether such disorders might contribute to circulatory disturbances in the diabetic myocardium. Norepinephrine induced a decrease in the conductivity of both coronary arterial bed and myocardial microcirculation in alloxan-diabetic dogs. It was markedly (p < 0.05) attenuated both by indomethacin and acetylsalicylic acid pretreatments indicating an imbalance among the vasoactive prostanoids in diabetes. TXA2 release from the diabetic coronary rings was found to be elevated and could be normalized after the blockade of vascular adrenoceptors by phentolamine (p < 0.05). PGIZ synthesis was also enhanced by adrenergic blockade in the diabetic arterial rings. After pretreatment with l4C arachidonic acid, in order to measure substrate availability, the arachidonic acid metabolic rate was less in the diabetic coronary arteries than in healthy vessels (p < 0.05). Ten µmol/1 norepinephrine decreased arachidonic acid metabolism in the presence of prelabelled substrate in the diabetic animals, compared to an increase observed in metabolically healthy dogs. Therefore diabetes appears to diminish arachidonic acid metabolism and uptake independent of adrenoceptors and to induce an imbalance between vasoconstrictor and vasodilator cyclooxygenase products, resulting in elevated TXA2 release controlled by adrenergic mechanisms which may contribute to an impairment in myocardial microcirculation.Abbreviations 6-oxo-PGF1
6-oxo prostaglandin F1
- HPLC
High Pressure Liquid Chromatograph
- LAD
Left Anterior Descending (coronary artery)
- PGI2
Prostacyclin
- TXA2
Thromboxane 相似文献
5.
The distribution of the pulmonary artery and vein of the orangutan lung was examined. The right pulmonary artery runs obliquely
across the ventral side of the right bronchus at the caudally to the right upper lobe bronchiole. It then runs across the
dorsal side of the right middle lobe bronchiole. Thereafter it runs obliquely across the dorsal side of the right bronchus,
and then along the dorso-medial side of the right bronchus. This course is different from that in other mammals. During its
course, it gives off branches which run mainly along the dorsal or lateral side of each bronchiole. The left pulmonary artery
runs across the dorsal side of the left middle lobe bronchiole, then along the dorso-lateral side of the left bronchus, giving
off branches which run along each bronchiole. The pulmonary veins run mainly the ventral or medial side of, along or between
the bronchioles. In the left lung, the left middle lobe vein has two trunks; one enters the left atrium, and the other enters
the left lower lobe pulmonary venous trunk. This is also different from that found in most mammals. Finally, the pulmonary
veins enter the left atrium with four large veins. 相似文献
6.
颈动脉内注入腺苷对呼吸,血压和肾交感神经活动的影响 总被引:3,自引:1,他引:2
在33只麻醉家兔,观察了颈动脉内注入腺苷所诱发的平均动脉压、心率,呼吸和肾交感神经活动的变化。结果如下:(1)颈动脉内注入腺苷后,平均动脉压呈剂量依赖性下降;呼吸加快,深度变化不明显,剪断窦神经后注入腺苷,仍引起平均动脉压下降,而呼吸变化消失。(2)隔离的颈动脉窦灌流液内加入腺苷后,平均动脉压下降,心率减慢;颈动脉体(CB)失活后反应消失。(3)将腺苷灌注到颈动脉窦区后,平均动脉压下降,肾交感神经传出放电活动增加,CB 失活或剪断窦神经后,反应消失。由此提示:腺苷可作为兴奋 CB 的一种物质,引起平均动脉压降低,心率减慢,呼吸加强和肾交感神经放电活动增加。 相似文献
7.
刺激家兔颈交感神经对颈动脉窦反射的影响 总被引:2,自引:0,他引:2
在36只麻醉家兔观察了电刺激颈交感神经(CSN)对颈动脉窦压力感受器(CSB)活动的影响。所得结果如下:(1)电刺激 CSN 可使夹闭颈动脉引起的加压反射消失或倒转,△BP 从刺激前的 39.5±3.6mmHg 变为刺激时的-0.31±5.4mmHg(P<0.001)。(2)在电刺激CSN 时,静注新福林所诱发的颈动脉窦压力感受器-心率反射增强,表现为反射性心率减慢较刺激前更为明显。(3)在以50—200mmHg 的压力充胀两侧颈动脉窦的条件下,刺激 CSN 引起窦内压与平均动脉压的关系曲线下移,与刺激前曲线相比有明显差异(P<0.01)。(4)切断 CSN 后,动脉血压有所升高,提示 CSN 对 CSB 活动有紧张性调节作用。以上结果比较明确地表明家兔 CSN 对 CSB 活动有调节作用。此作用可能是 CSN 作用于窦壁平滑肌而间接引起的。 相似文献
8.
在成年狗身上制备右侧孤离颈动脉窦,借助灌流装置用饱和氧的任氏液对其进行灌流。灌流压为搏动性的。通过改变每搏泵出量、灌流管道的阻力和弹性来调节灌流压及其变化速率。用多导生理记录仪同步记录股动脉血压、窦内灌流压及其变化速率。本文主要观察窦内压的变化速率对降压反射的影响。在8只狗身上共进行了93次实验。结果表明,在窦内压相同的情况下,灌流压的上升速率愈快,降压效应愈明显,而其下降速率则无显著作用。已有资料证明搏动性窦内压所引起的降压效应较非搏动性压力更为明显。由此可见,狗的颈动脉窦压力感受器不仅对搏动性压力而且对其上升的变化速率也很敏感。 相似文献
9.
10.
用离体血管电场刺激收缩模型观察到强啡肽明显抑制电场刺激引起的兔耳中心动脉及兔肠系膜上动脉的收缩效应,且呈剂量反应关系,而对股动脉的电场刺激收缩反应无明显影响,强啡肽抑制血管收缩达50%时的用量(IC_(50)值)分别为8.5±1.2×10~(-6)mol/L、5.02±1.3×10~(-7)mol/L及>10~(-6)mol/L。 用药物分析法看到,酚妥拉明(10~(-6)mol/L)可取消电场刺激及去甲肾上腺素引起的血管收缩作用,而强啡肽仅抑制电场刺激致血管收缩作用。 用HPLC法测定孵育液中去甲肾上腺素的含量变化时看到,应用强啡肽(5×10~(-7)mol/L)后孵育液中去甲肾上腺素的含量从对照组的340.56±73.13pg/ml下降至67.91±10.26pg/ml,两组差别有极显著意义(P<0.01)。纳洛酮(10~(-6)mol/L)可完全拮抗强啡肽的这一抑制效应。 以上结果提示强啡肽可能通过抑制交感神经末梢释放去甲肾上腺素,从而产生抑制血管的收缩作用。 相似文献